Stockscreener 앱 받기
14.32
1.63%
0.23
시간 외 거래:
14.32
전일 마감가:
$14.09
열려 있는:
$14.19
하루 거래량:
433.87K
Relative Volume:
0.74
시가총액:
$632.45M
수익:
$200.93M
순이익/손실:
$-18.91M
주가수익비율:
-32.41
EPS:
-0.4419
순현금흐름:
$-9.09M
1주 성능:
+2.29%
1개월 성능:
+11.96%
6개월 성능:
-5.91%
1년 성능:
+3.39%
1일 변동 폭
$14.00
$14.35
1주일 범위
$13.57
$14.85
52주 변동 폭
$12.15
$21.89
Si Bone Inc Stock (SIBN) Company Profile
명칭
Si Bone Inc
전화
(408) 207-0700
주소
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.32 | 622.29M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-08 | 개시 | Citigroup | Buy |
| 2021-03-09 | 재확인 | Needham | Buy |
| 2020-12-16 | 재확인 | Needham | Buy |
| 2020-08-04 | 재확인 | Needham | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-05 | 재확인 | Needham | Buy |
| 2020-02-19 | 개시 | Needham | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | BofA/Merrill | Buy |
| 2018-11-12 | 개시 | Canaccord Genuity | Buy |
| 2018-11-12 | 개시 | JMP Securities | Mkt Outperform |
| 2018-11-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Si Bone Inc 주식(SIBN)의 최신 뉴스
SI-BONE schedules May 11 earnings release, 4:30 p.m. ET call - Stock Titan
SiBone (NASDAQ:SIBN) Downgraded by Wall Street Zen to Hold - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) Q2 2025 Earnings Call Transcript - MSN
SiBone (NASDAQ:SIBN) Stock Price Down 4.8% on Analyst Downgrade - MarketBeat
Truist Financial Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $20 - Moomoo
Truist Financial Lowers SiBone (NASDAQ:SIBN) Price Target to $20.00 - MarketBeat
Truist Cuts Price Target on SI-BONE to $20 From $24, Keeps Buy Rating - marketscreener.com
(SIBN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
SiBone (NASDAQ:SIBN) Shares Down 6.8%Here's Why - MarketBeat
SI-BONE’s Long-Term Vision Takes Hold: Record Revenue Growth, Positive Adjusted EBITDA, and Expanding Innovation and Distribution - Orthopedics This Week
Bull Run: Is SI BONE Inc a turnaround story2026 Price Momentum & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Chart Watch: What is the earnings history of SI BONE Inc2026 EndofYear Setup & Free Community Consensus Stock Picks - baoquankhu1.vn
Director Greg Hinckley adds 3,085 SI-BONE (SIBN) shares via options - Stock Titan
Street Watch: Is SI BONE Inc stock showing strong momentum2026 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Investment Report: Can SI BONE Inc weather a recessionExit Point & Scalable Portfolio Growth Methods - baoquankhu1.vn
SiBone $SIBN Stake Lowered by JPMorgan Chase & Co. - MarketBeat
SiBone (NASDAQ:SIBN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Si-Bone CFO Maheshwari sells $42,707 in stock By Investing.com - Investing.com South Africa
SiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 1,799 Shares - MarketBeat
SiBone (NASDAQ:SIBN) CFO Sells $42,702.66 in Stock - MarketBeat
SiBone (NASDAQ:SIBN) SVP Sells $17,168.10 in Stock - MarketBeat
Si-Bone CFO Maheshwari sells $42,707 in stock - Investing.com
Tax-driven share sale by SI-BONE (SIBN) chief legal officer - Stock Titan
SI-BONE Inc stock: Why this medtech innovator could reshape spine surgery - AD HOC NEWS
Needham maintains SI-BONE (SIBN) buy recommendation - MSN
Will SI BONE Inc benefit from rising consumer demand2026 Historical Comparison & Fast Entry and Exit Trade Plans - baoquankhu1.vn
SI-BONE Inc Stock: Innovating Sacroiliac Joint Fusion in a Competitive Medtech Landscape - AD HOC NEWS
SiBone (NASDAQ:SIBN) Sees Large Growth in Short Interest - MarketBeat
SI-BONE raises 2025 revenue guidance to $195M-$198M with accelerated cash flow milestones - MSN
SiBone (NASDAQ:SIBN) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Vanguard files 13G/A showing 0 shares in SI-BONE (SIBN) - stocktitan.net
SiBone (NASDAQ:SIBN) Sets New 12-Month LowWhat's Next? - MarketBeat
Aug PostEarnings: What is the next catalyst for SI BONE Inc2026 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn
Piper Sandler reiterates SI-BONE stock rating on growth outlook By Investing.com - Investing.com Australia
Piper Sandler reiterates SI-BONE stock rating on growth outlook - Investing.com
Jim Cramer on SI-BONE, Inc.: "We're not going to buy the money losers" - MSN
(SIBN) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Stop Loss: Is SI BONE Inc stock showing strong momentumQuarterly Growth Report & Safe Entry Momentum Tips - baoquankhu1.vn
S P Trends: Is SI BONE Inc stock showing strong momentumQuarterly Market Review & Real-Time Volume Triggers - baoquankhu1.vn
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership - MSN
Granahan Investment Management LLC Sells 224,678 Shares of SiBone $SIBN - MarketBeat
SiBone $SIBN Shares Purchased by First Light Asset Management LLC - MarketBeat
Divisadero Street Capital Management LP Trims Holdings in SiBone $SIBN - MarketBeat
Nishimura Mika, Si-Bone director, sells $56k in SIBN stock - Investing.com
SiBone (NASDAQ:SIBN) Director Mika Nishimura Sells 4,100 Shares - MarketBeat
Insider Sell: Mika Nishimura Sells 4,100 Shares of SI-BONE Inc (SIBN) - GuruFocus
Si Bone Inc (SIBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):